Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios

Saved in:
Bibliographic Details
Published in:Journal of Health Economics and Outcomes Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1869572673059684352
collection WordPress RSS
FRELIP Feed Integration
container_title Journal of Health Economics and Outcomes Research
description
discipline_display Health and Safety
discipline_facet Health and Safety
format Online Article
RSS Article
genre Journal Article
id rss_article:98455
institution FRELIP
journal_source_facet Journal of Health Economics and Outcomes Research
last_indexed 2026-07-02T03:37:20.665Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
Health and Safety
General
Health and Safety
sub_discipline_display General
sub_discipline_facet General
subject_display Health and Safety
General
Health and Safety
subject_facet Health and Safety
General
Health and Safety
title Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
title_alt Costo-efectividad de semaglutida 2,4 mg para el manejo de la obesidad en Japón: un modelo económico de por vida que incorpora escenarios de retratamiento
Rentabilité du sémaglutide 2,4 mg pour la prise en charge de l'obésité au Japon : une étude de modélisation économique à vie intégrant des scénarios de retraitement
Custo-efetividade da semaglutida 2,4 mg para o manejo da obesidade no Japão: um modelo econômico ao longo da vida incorporando cenários de retratamento
title_auth Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
title_es_txt Costo-efectividad de semaglutida 2,4 mg para el manejo de la obesidad en Japón: un modelo económico de por vida que incorpora escenarios de retratamiento
title_fr_txt Rentabilité du sémaglutide 2,4 mg pour la prise en charge de l'obésité au Japon : une étude de modélisation économique à vie intégrant des scénarios de retraitement
title_full Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
title_fullStr Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
title_full_unstemmed Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
title_pt_txt Custo-efetividade da semaglutida 2,4 mg para o manejo da obesidade no Japão: um modelo econômico ao longo da vida incorporando cenários de retratamento
title_short Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
title_sort cost-effectiveness of semaglutide 2.4 mg for obesity disease management in japan: a lifetime economic modeling study incorporating retreatment scenarios
topic Health and Safety
General
Health and Safety
url https://jheor.org/article/162614-cost-effectiveness-of-semaglutide-2-4-mg-for-obesity-disease-management-in-japan-a-lifetime-economic-modeling-study-incorporating-retreatment-scenari